U
CBST

UBS’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

UBS’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$28.5M Buy
429,443
+34,720
+9% +$2.28M 0.02% 746
2014
Q2 		$27.6M Buy
394,723
+60,180
+18% +$4.09M 0.02% 708
2014
Q1 		$24.5M Sell
334,543
-19,102
-5% -$1.42M 0.02% 696
2013
Q4 		$24.4M Buy
353,645
+155,572
+79% +$10.1M 0.02% 693
2013
Q3 		$12.6M Buy
198,073
+44,321
+29% +$2.68M 0.01% 961
2013
Q2 		$7.42M Buy
+153,752
New +$7.56M 0.01% 1270

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

UBS's CBST Position: Q3 2014 in Review

UBS increased its CUBIST PHARMACEUTICALS INC (CBST) stake by 8.8% in Q3 2014, buying an estimated $2.28M and bringing the position to 429,443 shares worth $28.5M. The position accounts for 0.02% of the portfolio, ranked #746.

UBS first reported a position in CBST in Q2 2013 and has held it in 6 quarters since. 254 funds tracked by Wall St. Rank hold CBST as of Q3 2014.

  • UBS held 429,443 shares of CUBIST PHARMACEUTICALS INC worth $28.5M as of Q3 2014.
  • UBS bought 34,720 CUBIST PHARMACEUTICALS INC shares in Q3 2014, an estimated $2.28M.
  • CUBIST PHARMACEUTICALS INC made up 0.02% of UBS's portfolio in Q3 2014, its #746 holding.
  • UBS first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and has held it in 6 quarters since.
  • 254 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.